Literature DB >> 25175562

Prioritising prevention: implementation of IGT Care Call, a telephone based service for people at risk of developing type 2 diabetes.

Linda Ann Savas1, Katherine Grady2, Sarah Cotterill3, Lucinda Summers4, Ruth Boaden5, J Martin Gibson6.   

Abstract

AIM: To design, deliver and evaluate IGT Care Call, a telephone service providing a 6 month lifestyle education programme for people with impaired glucose tolerance (IGT).
METHODS: An observational study of IGT Care Call, a programme providing motivational support and education using electronic scripts. The service was delivered to 55 participants, all of whom completed the course (an information pack and at least five telephone calls over 6 months). Clinical measurements were undertaken in General Practice at baseline, on completion of the programme and one year later.
RESULTS: Among the 40 participants for whom we have complete data available, one year after discharge, participants showed improvements in fasting plasma glucose (0.29 mmol/l, 95% CI 0.07 to 0.51), weight (2.81 kg, 95% CI 1.20 to 4.42) and BMI (1.06 kg/m(2), 95% CI 0.49 to 1.63). All differences were statistically significant (p < 0.01).
CONCLUSION: Whilst an uncontrolled observational study with a small sample size, this pilot suggests IGT Care Call may be effective in promoting positive and sustained lifestyle changes to prevent type 2 diabetes, which warrants further investigation. A telephone method of service delivery was acceptable, convenient and may have improved self confidence in how to reduce risk of type 2 diabetes.
Copyright © 2014 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes prevention; Goal setting; Telephone service

Mesh:

Substances:

Year:  2014        PMID: 25175562     DOI: 10.1016/j.pcd.2014.07.003

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  7 in total

1.  Application of a tool for the evaluation of public and patient involvement in research.

Authors:  Susan Jill Stocks; Sally J Giles; Sudeh Cheraghi-Sohi; Stephen M Campbell
Journal:  BMJ Open       Date:  2015-03-13       Impact factor: 2.692

Review 2.  A narrative systematic review of factors affecting diabetes prevention in primary care settings.

Authors:  Josie Messina; Stephen Campbell; Rebecca Morris; Emily Eyles; Caroline Sanders
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

3.  The Effect of Technology-Mediated Diabetes Prevention Interventions on Weight: A Meta-Analysis.

Authors:  Rachel R Bian; Gretchen A Piatt; Ananda Sen; Melissa A Plegue; Mariana L De Michele; Dina Hafez; Christina M Czuhajewski; Lorraine R Buis; Neal Kaufman; Caroline R Richardson
Journal:  J Med Internet Res       Date:  2017-03-27       Impact factor: 5.428

4.  Data Independent Acquisition Mass Spectrometry Can Identify Circulating Proteins That Predict Future Weight Loss with a Diet and Exercise Programme.

Authors:  Nagaraj Malipatil; Helene A Fachim; Kirk Siddals; Bethany Geary; Gwen Wark; Nick Porter; Simon Anderson; Rachelle Donn; Michelle Harvie; Anthony D Whetton; Martin J Gibson; Adrian Heald
Journal:  J Clin Med       Date:  2019-01-25       Impact factor: 4.241

5.  Lifestyle intervention in individuals with impaired glucose regulation affects Caveolin-1 expression and DNA methylation.

Authors:  Helene A Fachim; Kirk Siddals; Nagaraj Malipatil; Rachelle P Donn; Gabriela Yc Moreno; Caroline F Dalton; Safwaan Adam; Handrean Soran; J Martin Gibson; Adrian H Heald
Journal:  Adipocyte       Date:  2020-12       Impact factor: 4.534

Review 6.  A systematic review of real-world diabetes prevention programs: learnings from the last 15 years.

Authors:  Zahra Aziz; Pilvikki Absetz; John Oldroyd; Nicolaas P Pronk; Brian Oldenburg
Journal:  Implement Sci       Date:  2015-12-15       Impact factor: 7.327

7.  Comparison of active treatments for impaired glucose regulation: a Salford Royal Foundation Trust and Hitachi collaboration (CATFISH): study protocol for a randomized controlled trial.

Authors:  Peter A Coventry; Peter Bower; Amy Blakemore; Liz Baker; Mark Hann; Angela Paisley; Charlotte Renwick; Jinshuo Li; Atushi Ugajin; Martin Gibson
Journal:  Trials       Date:  2016-08-26       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.